Referred to the House Committee on the Judiciary.
The bill creates a federal civil cause of action for individuals who received ‘‘gender-related medical treatment’’ while they were minors. Eligible plaintiffs (or their guardians/estate representatives) may sue each person who performed the treatment and recover actual damages or liquidated damages of $250,000 per instance, plus fees and costs.
Whether the bill protects minors from harm (conservative view) versus whether it will chill access to evidence‑based gender‑affirming care and harm transgender youth (liberal view).
Relative to its intended legislative type, this bill is a clear substantive proposal to create a federal private cause of action for specified gender-related medical treatments performed on minors.
The bill creates a federal civil cause of action for individuals who received ‘‘gender-related medical treatment’’ while they were minors.
Eligible plaintiffs (or their guardians/estate representatives) may sue each person who performed the treatment and recover actual damages or liquidated damages of $250,000 per instance, plus fees and costs.
The bill defines an extensive list of covered treatments (surgeries, hormones, puberty blockers, and related procedures) for people described as female or male, and it excludes treatments for diagnosed disorders of sex development and some related medical care.
On content alone, the bill addresses a highly disputed policy area and creates strong federal liability incentives without built-in compromise measures. While a chamber with a favorable majority could pass it, the lack of bipartisan features, anticipated stakeholder opposition, substantial litigation risk, and the higher procedural and coalition requirements in the other chamber make enactment unlikely unless broader political conditions strongly favor it.
Relative to its intended legislative type, this bill is a clear substantive proposal to create a federal private cause of action for specified gender-related medical treatments performed on minors. It is relatively strong in defining covered procedures and setting out the fundamental remedy framework, but it omits several common and important legal and procedural particulars that are normally expected when creating a new federal cause of action.
Whether the bill protects minors from harm (conservative view) versus whether it will chill access to evidence‑based gender‑affirming care and harm transgender youth (liberal view).
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether the bill protects minors from harm (conservative view) versus whether it will chill access to evidence‑based gender‑affirming care and harm transgender youth (liberal view).
This persona would likely view the bill as a federal attack on access to gender-affirming care for transgender youth and on parental and clinician decision-making.
They would see the bill’s broad private right of action, large liquidated damages, and the expansive definition of covered ‘‘gender-related medical treatment’’ as likely to chill providers and reduce available, evidence‑based care.
The redefinition of ‘‘gender’’ to mean ‘‘sex’’ and the placement of the issue in federal civil law would be viewed as ideologically driven and harmful to transgender civil rights.
A centrist would approach the bill pragmatically and notice both aims and problems.
They may accept the objective of protecting minors from harmful, irreversible procedures but worry the measure is broadly written, federalizes state medical regulation, and imposes very large damages with limited procedural detail.
They would be concerned about ambiguity (e.g., what counts as an ‘‘instance,’’ retroactivity, statute of limitations, and the absence of an affirmative defense for accepted medical practice).
This persona would likely view the bill favorably as a tool to protect minors from irreversible gender‑related medical procedures and to hold providers accountable.
They would appreciate the creation of a private right of action with substantial damages as a deterrent and the use of interstate‑commerce language to reach providers who travel or advertise across state lines.
They may see the statutory definitions of sex and gender as clarifying and aligned with their policy goals.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill addresses a highly disputed policy area and creates strong federal liability incentives without built-in compromise measures. While a chamber with a favorable majority could pass it, the lack of bipartisan features, anticipated stakeholder opposition, substantial litigation risk, and the higher procedural and coalition requirements in the other chamber make enactment unlikely unless broader political conditions strongly favor it.
The bill has not accumulated any surfaced votes yet.
Whether the bill protects minors from harm (conservative view) versus whether it will chill access to evidence‑based gender‑affirming care…
On content alone, the bill addresses a highly disputed policy area and creates strong federal liability incentives without built-in comprom…
Relative to its intended legislative type, this bill is a clear substantive proposal to create a federal private cause of action for specified gender-related medical treatments performed on minors. It is relatively stro…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.